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Introduction
Id-1 (inhibitor of differentiation or DNA binding) is a member of the helix-loop-helix (HLH) proteins. It lacks the basic domain for DNA binding and functions as a dominant inhibitor of the basic HLH transcription factors by forming heterodimers, thus inhibiting gene expression (1) . Increased expression of Id-1 has been found in many types of human cancer including esophageal squamous cell carcinoma (ESCC) (2) . Recently, Id-1 has been shown to play an important role in the regulation of cell proliferation and survival in human cancers (3, 4) . In addition, Id-1 promotes invasion and metastasis of human cancers (5) , and the level of Id-1 protein expression is associated with poor prognosis in several types of cancers (6, 7) . Id-1, therefore, may play a critical role in tumorigenesis and cancer progression. The oncogenic function of Id-1 may involve multiple signaling pathways. In prostate, nasopharyngeal and hepatocellular cancer cells, for example, Id-1 induces serum-independent cell proliferation which is associated with inactivation of the p16/Rb pathway (3, 8, 9) . The growth promoting function of Id-1 also involves activation of the MAPK (Mitogen-Activated Protein Kinase) signaling pathway in prostate cancer cells (3, 10) .
In our recent paper, we reported that Id-1-induced cell proliferation of esophageal cancer cells was associated with up-regulation of MDM2 (mouse double minute 2), but not the key members of the p16/Rb pathway (11) . Our findings suggest that the oncogenic function of Id-1 in esophageal cancer may preferentially involve signaling pathways different from that of other cancers.
Phosphatidylinositol-3-kinase (PI3K) is a lipid kinase that generates second messengers involved in regulation of a wide spectrum of cellular functions including proliferation, survival and invasion (12) . One of its major effectors is Akt (protein kinase B). The PI3K/Akt pathway is frequently activated in many types of human cancers including ESCC (13) (14) (15) , and has been linked to cancer development for some time. The pathway controls several growth-regulatory transcription factors. One of the prominent examples is nuclear factor kappa B (NFκB) (16, 17) , a heterodimeric transcription factor that is sequestered in the cytoplasm as an inactive form by inhibitor of κB (IκB) (18). Phosphorylation of IκB frees NFκB, and allows its nuclear translocation, binding and subsequent activation of target genes (19). In addition to being involved in immune and inflammatory responses, NFκB also regulates cell proliferation, apoptosis and migration, and is constitutively activated in a number of human cancers including ESCC (20) (21) (22) . Therefore, these evidences suggest that the PI3K/Akt/NFκB signaling pathway may be associated with tumorigenesis in ESCC.
However, the mechanism responsible for PI3K/Akt/NFκB activation in ESCC is largely unknown. 
Materials and Methods

Cell culture and drugs
Human ESCC cell line, HKESC-3 was established from a well-differentiated ESCC (25) . The cell line has serum-dependent Id-1 expression. The establishment of stable Id-1 expressing clones and empty vector control clones from this cell line was described previously (11) . The pooled stable transfectants, designated HKESC-3-Id-1 and HKESC-3-pBabe, respectively, and another ESCC cell line KYSE510 with high endogenous Id-1 expression even under serum-starved condition (26) were maintained in RPMI 1640 (Sigma, St Louis, MO, USA) supplemented with 10% fetal bovine serum (FBS) (Invitrogen, Gaithersburg, MD, USA) at 37ºC in 5% CO 2 . The HEK293 cell line, obtained from American Type Culture Collection (Rockville, MD, USA), was maintained in DMEM (Sigma) supplemented with 10% FBS. TNF-α (PeproTech EC, London, UK) was diluted in culture medium to obtain the desired concentration. Unless specified otherwise, the HKESC-3-Id-1 and HKESC-3-pBabe cells were cultured in serum-free medium for 24 h before treatment or collection.
Expression vector and transient transfection
The vector containing full length Id-1 cDNA (pcDNA3-Id-1) or empty vector control (pcDNA3) (27) was transiently transfected into HEK293 cells using Fugene 6 transfection reagent (Roche Diagnostics, GmbH, Mannheim, Germany) according to the manufacture's protocol. Cells were collected 48 h after transfection for Western blot.
Knockdown of Id-1 expression using siRNA
A siRNA duplex targeting Id-1 (si-Id-1) was purchased from Dharmacon (Chicago, USA) and dissolved in RNase-free distilled water. The siRNA target site is 
Preparation of nuclear extracts
Cells (5×10 6 ) collected after trypsinization were washed with ice-cold PBS and the pellet resuspended in 200 µl of ice-cold Buffer A (10 mM HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, 2.5 µg/ml leupeptin, 1 ug/ml aprotinin, 1 mM DTT, 1 µg/ml NaF and 0.5 mM PMSF). After incubation on ice for 15 min, 10 µl of 1% Nonidet P-40 (NP-40)
was added. The mixture was left at room temperature for 4 min, and then vortexed vigorously for 20 s. The cell nuclear pellet was collected by centrifugation at 3000 rpm for 3 min, washed with 100 µl of Buffer A, and collected again by centrifugation.
The pellet was then resuspended in 50 µl of Buffer C (20 mM HEPES pH 7.9, 0.4 M NaCl, 1mM EDTA, 2.5 µg/ml leupeptin, 1 µg/ml aprotinin, 1 mM DTT, 1 µg/ml NaF and 1 mM PMSF), shaken vigorously at 4ºC for 15 min and then centrifuged at 14000 rpm for 15 min at room temperature. The supernatant was recovered as nuclear extract and then transferred to a fresh Eppendorf tube containing 10% v/v of glycerol. The protein concentration was assayed using Bio-rad Dc protein assay kit (Bio-rad, Hercules, CA, USA) before use for Western blotting or Electrophoretic-Mobility Shift Assay (EMSA).
Western blot analyses
Preparation of whole cell lysates and immunoblotting were described previously (11, 29 
Electrophoretic Mobility Shift Assay (EMSA)
NFκB DNA-binding activity was detected using an EMSA kit (Panomics, Redwood, CA, USA) according to manufacture's instruction. Briefly, the nuclear extract was incubated in 1×binding reaction mixture including biotin-labeled double-stranded NFκB consensus oligonucleotide for 30 min at 20ºC. The mixture was separated on a non-denaturing polyacrylamide gel and then transferred to a nylon membrane (Amersham). The membrane was baked for 1 h at 80ºC in a dry oven, then transferred to a UV crosslinker oven for 3 min. The shifted bands corresponding to the protein/DNA complexes were visualized relative to the unbound dsDNA. The bands were visualized after exposure to BioMax Light Film (Kodak, Rochester, NY).
TdT-mediated dUTP Nick-End Labeling (TUNEL) Assay
End labeling of exposed 3' OH ends of DNA fragments was undertaken with the 
Effect of Id-1 expression on NFκB signaling pathway
We next investigated whether Id-1 expression had any effect on NFκB activity. Since NFκB translocates to the nucleus upon activation, we studied the expression of the most abundant subunit of NFκB, p65, in the nuclear extracts and whole lysates of Figure   3D ). Taken together, these observations support that Id-1 functions as an upstream regulator of the NFκB signaling pathway.
Id-1 induced NFκB activation is mediated through PI3K/Akt
Since NFκB is a downstream target of PI3K/Akt signaling pathway (16, 17) , and our results above indicated that Id-1 activated both PI3K/Akt and NFκB, we hypothesized that PI3K/Akt signaling pathway is required for the Id-1 activation of NFκB. As shown in Figure 3E , inhibition of PI3K activity in HKESC-3-Id-1 cells using the 
Discussion
In this study, our results indicate for the first time that Id-1 induces activation of the PI3K/Akt/NFκB signaling pathway, which may be one of the mechanisms responsible for protecting ESCC cells from TNF-α induced apoptosis.
Several novel points arise from this study. First, we provide the first evidence that Id-1 is an upstream regulator of the PI3K/Akt pathway (Figures 1 and 2 ). Our finding Since MDM2 is a direct target of Akt (12) and is known to induce cell proliferation by directly stimulating E2F-1 (34), it is possible that Id-1 acts through PI3K/Akt and MDM2 to drive G1/S progression. In addition to growth stimulation and anti-apoptotic function, Id-1 is known to promote invasion and metastasis of breast cancer cells (35, 36) . Since PI3K/Akt/NFκB is documented to be involved in the regulation of cellular invasion and metastasis (12, 37) , it may be one of the mechanisms by which Id-1 exerts its effects on cancer progression. Down-regulation of Id-1 led to reduced phosphorylation of Akt and GSK3β, while the total levels of these proteins remained unchanged. Western blots of Id-2, -3 and -4
were included to verify that the siRNA used was specific to Id-1 but not the other Id proteins. 
